Maria Gomis‐González
Neurosciences Institute(US)Hospital Del Mar(ES)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Cannabis and Cannabinoid Research, Nutritional Studies and Diet, Diet and metabolism studies, Down syndrome and intellectual disability research
Most-Cited Works
- → Targeting the endocannabinoid system in the treatment of fragile X syndrome(2013)236 cited
- → Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure(2013)115 cited
- → Dissociation of the Pharmacological Effects of THC by mTOR Blockade(2013)95 cited
- → Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation(2016)80 cited
- → Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model(2016)58 cited
- → Interplay between cognition and weight reduction in individuals following a Mediterranean Diet: Three-year follow-up of the PREDIMED-Plus trial(2021)45 cited
- → An Alternative Maze to Assess Novel Object Recognition in Mice(2020)36 cited
- → Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome(2019)36 cited
- → Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol(2017)34 cited
- → Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)(2022)33 cited